Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Hydroxyurea. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxyurea SCHEMBL93814 | 1.00 | LMNA (1.00) | — | |
| Hydroxyurea SCHEMBL5329855 | 1.00 | LMNA (1.00) | — | |
| Hydroxyurea SCHEMBL28164447 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL28783824 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL27583606 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL23274911 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL306433 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL15011410 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL308240 | 0.95 | — | — | |
| Hydroxyurea SCHEMBL28868410 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 161630 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| US-12635917-B2 | Remote blood volume monitor | DAXOR CORP. (US) | 2026-05-26 | — | — | US | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| WO-2026107472-A1 | TREATMENT OF SICKLE CELL DISEASE, VASO-OCCLUSIVE CRISES-ASSOCIATED DISEASES, AND/OR THROMBOSIS WITH A HEMOGLOBINASE ENZYME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260137685-A1 | SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF | IMPACT THERAPEUTICS SHANGHAI INC (CN) | 2026-05-21 | — | — | US | claimed |
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137686-A1 | SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF | IMPACT THERAPEUTICS SHANGHAI INC (CN) | 2026-05-21 | — | — | US | claimed |
| WO-2026105121-A1 | ANTICANCER FORMULATIONS AND USES THEREOF | INTRAGEL THERAPEUTICS LTD. (IL) | 2026-05-21 | — | — | WO | claimed |
| WO-1981000256-A1 | (N-PHOSPHONACETYL-L-ASPARTATO)(1,2-DIAMINOCYCLOHEXANE)-PLATINUM(II)OR ALKALI METAL SALT | US COMMERCE (US) | 1981-02-05 | — | — | WO | claimed |
| EP-0010964-A1 | Ravidomycin, process of preparation and pharmaceutical compositions containing same | AYERST, MCKENNA AND HARRISON INC. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4202890-A | 4-Carboxy-phthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof with cyclophosphamide and hydroxyurea in alleviating L1210 murine leukemia | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) | 1980-05-13 | — | — | US | claimed |
| US-4148887-A | SUGAR ESTER WITH A METHYL SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4147767-A | CROSSLINKED WITH FORMALDEHYDE OR GLUTARALDEHYDE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1979-04-03 | — | — | US | claimed |
| US-4108001-A | EPOXY RESIN, THERMAL PROTECTION FOR ELECTRICAL APPARATUS | WESTINGHOUSE ELECTRIC CORP. (US) | 1978-08-22 | — | — | US | claimed |
| US-3968249-A | HYDROXYUREA | E. R. SQUIBB & SONS, INC. (US) | 1976-07-06 | — | — | US | claimed |
| US-3965254-A | Compositions for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1976-06-22 | — | — | US | claimed |
| US-3964912-A | Ruthenium containing photographic developers | EASTMAN KODAK COMPANY (US) | 1976-06-22 | — | — | US | claimed |
| US-3957990-A | INSECTICIDES, ACARICIDES | MORTON-NORWICH PRODUCTS, INC. (US) | 1976-05-18 | — | — | US | claimed |